Company Filing History:
Years Active: 2015-2025
Title: The Innovative Contributions of Olaf Haeusler
Introduction
Olaf Haeusler is a notable inventor based in Fletre, France. He has made significant contributions to the field of medical technology, particularly in the area of glucose polymers and protein stabilization. With a total of 5 patents to his name, Haeusler's work has the potential to impact various medical applications.
Latest Patents
Haeusler's latest patents include groundbreaking inventions such as glucose polymers for peritoneal dialysis. This invention relates to a novel glucose polymer that is particularly useful for administration by the parenteral route. It also encompasses methods for the production of these polymers and their use as medicaments, specifically as osmotic agents for peritoneal dialysis. Another significant patent involves the use of specific combinations of carbohydrates for stabilizing proteins. This invention highlights a combination of a polyol consisting of 12 carbon atoms and another polyol consisting of 4 to 6 carbon atoms as effective protein stabilizers. Additionally, it includes protein compositions that utilize this combination and processes for preparing such compositions.
Career Highlights
Haeusler is currently associated with Roquette Freres, a company known for its expertise in food and pharmaceutical ingredients. His role at the company allows him to leverage his innovative ideas and contribute to advancements in medical technology.
Collaborations
Throughout his career, Haeusler has collaborated with esteemed colleagues such as Daniel Wils and Juergen Siepmann. These collaborations have likely enriched his research and development efforts, leading to the successful creation of his patented inventions.
Conclusion
Olaf Haeusler's contributions to the field of medical technology through his innovative patents demonstrate his commitment to improving healthcare solutions. His work in glucose polymers and protein stabilization is paving the way for advancements in medical treatments.